ArticleBMC nephrology2014
Paediatric end-stage renal disease in a tertiary hospital in South West Nigeria.
Article in BMC nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- The incidence of and risk factors for late presentation of childhood chronic kidney disease: A systematic review and meta-analysis.PloS one · 2020Pooled it
- Kidney disease among children in sub-Saharan Africa: systematic review.Pediatric research · 2015Pooled it
- A review of congenital anomalies of the kidney and urinary tract (CAKUT) in Africa.Annals of medicine and surgery (2012) · 2026Review
- Regional variation of underlying kidney diseases in children undergoing chronic kidney replacement therapy around the globe.Pediatric nephrology (Berlin, Germany) · 2026Article
- The Impact of Exercises and Physical Activity Programs on Paediatric Patients Undergoing Haemodialysis in Africa: A Scoping Review.Healthcare (Basel, Switzerland) · 2026Review
- Inequitable paediatric kidney transplantation in resource-limited countries: expert recommendations for Nigeria - a scoping review.BMJ global health · 2025Article
- Clinical Outcomes of a Dedicated Kidney Adolescent and Young Adult Clinic (KAYAC) in South Africa.Nephrology (Carlton, Vic.) · 2025Article
- Catastrophic healthcare expenditure and caregiver burden in pediatric chronic kidney disease - a mixed methods study from a low resource setting.Pediatric nephrology (Berlin, Germany) · 2024Article
- Evaluation of eGFR methods in a sub-Saharan African community-based pediatric population.Pediatric nephrology (Berlin, Germany) · 2024Article
- Spectrum of congenital anomalies of the kidney and urinary tract in a pediatric nephrology clinic in Ethiopia and factors associated with advanced chronic kidney disease: A cross-sectional study.PLOS global public health · 2024Article
- Burden of Paediatric Kidney Diseases in a Tertiary Care Hospital in Harare, Zimbabwe.Clinical medicine insights. Pediatrics · 2023Article
- Addressing the Ethical Challenges of Providing Kidney Failure Care for Children: A Global Stance.Frontiers in pediatrics · 2022Review
- The current status of kidney transplantation in Nigerian children: still awaiting light at the end of the tunnel.Pediatric nephrology (Berlin, Germany) · 2021Article
- Paediatric Nephrology in Africa.Current pediatrics reports · 2021Review
- Challenges of access to kidney care for children in low-resource settings.Nature reviews. Nephrology · 2021Review
- Management of idiopathic childhood nephrotic syndrome in sub-Saharan Africa: Ibadan consensus statement.Kidney international · 2021Article
- Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research.Ecancermedicalscience · 2020Article
- Renal abnormalities and its associated factors among school-aged children living inTropical medicine and health · 2020Article
- Survival in children requiring chronic renal replacement therapy.Pediatric nephrology (Berlin, Germany) · 2018Review
- Inequalities in access to pediatric ESRD care: a global health challenge.Pediatric nephrology (Berlin, Germany) · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
Abstract
backgroundChildren and adolescents with end-stage renal disease (ESRD) in sub-Saharan Africa may have the worst outcomes globally. Barriers to management include late presentation, poor socioeconomic conditions, absence of medical insurance, limited diagnostic facilities and non-availability of chronic renal replacement therapy (RRT). Our study was to determine the incidence, aetiology, management and outcomes of paediatric ESRD in a tertiary hospital in Nigeria.
methodsA retrospective case review of paediatric ESRD at the University College Hospital Ibadan, Nigeria, over 8 years, from January 2005 to December 2012.
results53 patients (56.6% male), median age 11 (inter quartile range 8.5-12) years were studied. Mean annual incidence of ESRD in Ibadan for children aged 14 years and below was 4 per million age related population (PMARP) while for those aged 5-14 years it was 6.0 PMARP. Glomerulonephritis was the cause in 41 (77.4%) patients amongst whom, 29 had chronic glomerulonephritis and 12 had nephrotic syndrome. Congenital anomalies of the kidneys and urinary tract (CAKUT) accounted for 11 (21.2%) cases, posterior urethral valves being the most common. Acute haemodialysis, acute peritoneal dialysis or a combination of these were performed in 33 (62.3%), 6 (11.3%) and 4 (7.5%) patients respectively. Median survival was 47 days and in-hospital mortality was 59%.
conclusionsIncidence of paediatric ESRD in Ibadan is higher than previous reports from sub-Saharan Africa. Glomerulonephritis, and then CAKUT are the most common causes. Mortality is high, primarily due to lack of resources. Preventive nephrology and chronic RRT programmes are urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.